NONOates regulate KCl cotransporter-1 and -3 mRNA expression in vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Di Fulvio, Mauricio ^a   Lauf, Peter K ^a   Shah, Shalin ^a   Adragna, Norma C ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Nitric oxide; Soluble guanylyl cyclase

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 3 [2 HYDROXY 1 (1 METHYLETHYL) 2 NITROSOHYDRAZINO] 1 PROPANAMINE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 6 (2 HYDROXY 1 METHYL 2 NITROSOHYDRAZINO) N METHYLHEXANAMINE; 6 ANILINO 5,8 QUINOLINEQUINONE; COTRANSPORTER; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; MESSENGER RNA; NITRIC OXIDE DONOR; POTASSIUM CHLORIDE; POTASSIUM CHLORIDE COTRANSPORTER 1; POTASSIUM CHLORIDE COTRANSPORTER 3; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SOLUBILITY; TIME; UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0344406088     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00710.2002     Document Type: Article

References (26)

1. Adragna NC and Lauf PK. Role of nitrite, a nitric oxide derivative, in KCl cotransport activation of low-potassium sheep red blood cells. J Membr Biol 166: 157-167, 1998.
2. Adragna NC, White RE, Orlov SN, and Lauf PK. KCl cotransport in vascular smooth muscle and erythrocytes: possible implication in vasodilation. Am J Physiol Cell Physiol 278: C381-C390, 2000.
3. Adragna NC, Zhang J, Di Fulvio M, Lincoln TM, and Lauf PK. KCl cotransport regulation and protein kinase G in cultured vascular smooth muscle cells. J Membr Biol 187: 157-165, 2002.
4. Andreopoulos S and Papapetropoulos A. Molecular aspects of soluble guanylyl cyclase regulation. Gen Pharmacol 34: 147-157, 2000.
5. Artz JD, Toader V, Zavorin SI, Bennett BM, and Thatcher GR. In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics. Biochemistry 40: 9256-9264, 2001.
6. Bogdan C. Nitric oxide and the regulation of gene expression. Trends Cell Biol 11: 66-74, 2001.
7. Bouton C and Demple B. Nitric oxide-inducible expression of heme oxygenase-1 in human cells: translation-independent stabilization of the mRNA and evidence for direct action of NO. J Biol Chem 275: 32688-32693, 2000.
8. Carvajal JA, Germain AM, Huidobro-Toro JP, and Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184: 409-420, 2000.
9. Di Fulvio M, Lauf PK, and Adragna NC. Nitric oxide signaling pathway regulates potassium chloride cotransporter-1 mRNA expression in vascular smooth muscle cells. J Biol Chem 276: 44534-44540, 2001.
10. Di Fulvio M, Lincoln TM, Lauf PK, and Adragna NC. Protein kinase G regulates potassium-chloride cotransporter-3 expression in primary cultures of rat vascular smooth muscle cells. J Biol Chem 276: 21046-21052, 2001.
11. Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch Pharmacol 358: 113-122, 1998.
12. Hofmann F, Ammendola A, and Schlossman J. Rising behind NO: cGMP-dependent protein kinases. J Cell Sci 113: 1671-1676, 2000.
13. Hrabie JA and Klose JR. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 58: 1472-1476, 1993.
14. - transport The volume-sensitive parameter is the rate constant for inactivation. J Gen Physiol 95: 1021-1040, 1990.
15. Komalavilas P, Shah PK, Jo H, and Lincoln TM. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem 274: 34301-34309, 1999.
16. Lauf PK and Adragna NC. KCl cotransport: properties and molecular mechanism. Cell Physiol Biochem 10: 341-354, 2000.
17. Lauf PK, Bauer J, Adragna NC, Fujise H, Zade-Oppen AM, Ryu KH, and Delpire E. Erythrocyte KCl cotransport: properties and regulation. Am J Physiol Cell Physiol 263: C917-C932, 1992.
18. Lee YC, Martin E, and Murad F. Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. Proc Natl Acad Sci USA 97: 10763-10768, 2000.
19. Lincoln TM, Cornwell TL, Komalavilas P, and Boerth N. Cyclic GMP-dependent protein kinase in nitric oxide signaling. Methods Enzymol 269: 149-166, 1996.
20. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, and Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375-413, 2000.
21. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, and Keefer LK. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34: 3242-3247, 1991.
22. Moncada S, Palmer RM, and Higgs. Nitric oxide: physiology EA, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
23. Mount DB, Mercado A, Song L, Xu J, George AL Jr, Delpire E, and Gamba G. Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family. J Biol Chem 274: 16355-16362, 1999.
24. 2+-induced LDL oxidation by nitric oxide: a study using donors with different half-time of NO release. Biochem Biophys Res Commun 220: 306-309, 1996.
25. Uehara T, Kikuchi Y, and Nomura Y. Caspase activation accompanying cytochrome c release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SHSY5Y cells. J Neurochem 72: 196-205, 1999.
26. Yoshida K, Akaike T, Doi T, Sato K, Ijiri S, Suga M, Ando M, and Maeda H. Pronounced enhancement of NO-dependent antimicrobial action by an NO-oxidizing agent, imidazolineoxyl N-oxide. Infect Immun 61: 3552-3555, 1993.